Showing results (151-160 of 412) with videos related to
Sort By:
Pageof 42
Biochemical Pharmacology|March 15, 2006
Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cellsMichael Höpfner, Alexander Huether, Andreas P Sutter, et al.World Journal of Gastroenterology|August 29, 2006
Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancerAlexander Huether, Michael Hopfner, Andreas P Sutter, et al.Journal of Hepatology|December 8, 2004
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinomaMichael Höpfner, Andreas P Sutter, Alexander Huether, et al.Biochemical and Biophysical Research Communications|October 12, 2004
Cell cycle-related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cellsKerstin Maaser, Andreas P Sutter, Antje Krahn, et al.The Annals of Thoracic Surgery|May 1, 1993
Augmented femoral venous returnL Solomon, F P Sutter, S M Goldman, et al.Science (New York, N.Y.)|May 23, 1998
A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotinJ Rao, J Lahiri, L Isaacs, et al.Biochemical Pharmacology|April 15, 2004
Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinaseAndreas P Sutter, Kerstin Maaser, Bastian Gerst, et al.Journal of Hepatology|August 9, 2005
Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptorAndreas P Sutter, Kerstin Maaser, Michael Höpfner, et al.American Journal of Preventive Medicine|January 18, 2018
Gender Identity Disparities in Cancer Screening BehaviorsAriella R Tabaac, Megan E Sutter, Catherine S J Wall, et al.Urology|June 28, 2000
Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical centerS J Freedland, M Jalkut, F Dorey, et al.Pageof 42